http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2051239-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-657181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65742
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
filingDate 1991-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72053d360d7b4b77c75dd419520adcbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d523124edc393d3816c6fee50b9bb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c03e85ecb6bf12ecfc5dccfbec78badd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e5962f65573207542b205d5d457769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b646c33ddc6ca256ef1472ff05ac7442
publicationDate 1992-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2051239-A1
titleOfInvention Prodrugs of phosphonates
abstract There are disclosed novel oral prodrugs of phosphonate nucleotide analogs which are hydrolyzable under physiological conditions to yield compounds which are useful as antiviral agents, especially as agents effective against RNA and DNA viruses. They may also find use as antitumor agents.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9319075-A1
priorityDate 1990-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414022007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969

Total number of triples: 36.